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INTRODUCTION 
      Cerebrovascular diseases include one of most common and 
devastating disorders worldwide. These include ischemic stroke, 
haemorrhagic stroke, AV malformations, and intracranial 
aneurysms. This causes one of the major causes of disability. There 
are major risk factors for the stroke which can be prevented by 
awareness and prevention programs and warning signals by the 
public and stress on the preventive training in medical education 
will reduce the stroke prevention gap. 
 
            There is a growing interest in the pathogenesis of ischemic 
stroke because nearly fifty percent of cerebrovascular disease risk 
factors identified were traditional risk factors. Hence leads to 
search for new risk factors and treatment. The markers of 
inflammation like C- reactive protein, intracellular adhesion 
molecule-1, lipoprotein associated phospholipase A2, increased 
white blood cell count, endothelial nitric oxide synthase, infectious 
etiologies like Chlamydiae pneumonia, Helicobacter pylori and 
cytomegalovirus, Homocysteine, Tissue factor Fibrinogen, 
Lipoprotein (a), Small dense LDL, cytokine transforming growth 
factor, etc, have been identified as new risk factors for stroke. 
Another upcoming risk factor for the growing list is said to be 
microalbuminuria. 
 
Microalbuminuria has been associated with disease like 
diabetic nephropathy, hypertension with left ventricular 
hypertrophy and renal insufficiency etc. Microalbuminuria has 
been associated with risk factors for stroke like diabetes, 
hypertension aging, history of myocardial infarction, obesity, 
smoking. But there was meager knowledge in connection as  
independent risk factor for stroke or as a predictor of stroke 
outcome. So there were many studies in the world to demonstrate 
the microalbuminuria as a   risk factor for stroke and predictor of 
stroke outcome in non diabetic individuals. 
 
 
 
 
 
 
  
 
AIMS AND OBJECTIVES 
 
1. To determine the presence of microalbuminuria in the recent 
ischemic cerebrovascular disease who are non – diabetic 
individuals. 
2. To study the prognostic significance of microalbuminuria in recent 
ischemic cerebrovascular individuals. 
 
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
ISCHEMIC STROKE 
DEFINITION 
Stroke 
            A stroke or cerebrovascular accident is defined by abrupt 
onset of neurological deficit that is attributable to focal vascular 
cause. Thus the definition of stroke is clinical and laboratory 
studies including the brain imaging support the diagnosis. 
Transient Ischemic Attack 
         TIA is defined that neurological signs and symptoms resolve 
within 24 hours regardless whether there is imaging evidence of 
new permanent brain injury. 
  TIA per se does not impose any lasting burden on the 
individual or the society. But it serves as warning signal for later 
occurrence of stroke and thus may form the basis of high risk 
prevention strategy. 
 
 
Stroke in Evolution  
         Is a progressive neurological deficit developing over few 
hours or days, which evolves to Completed stroke after a few hours 
or days. 
Completed Stroke  
       Is a stroke syndrome in which the deficit is prolonged and 
often permanent causing demonstrable parenchymal damage. 
Small Vessel Stroke 
         Is the infarction following atherothrombotic or lipohyalinotic 
occlusion of a small  artery in the Brain 
 
 
 
 
 
 
 
CLASSIFICATION  
Oxfordshire   stroke  sub – classification 
A.   Anterior Circulation Syndrome (total) 
It is a stroke   involving a big cortical area  either MCA or both 
MCA AND ACA  territories. 
    It   consists   of: 
  cerebral  dysfunction  
 Homonymous visual field defect. 
 Both motor and sensory deficit involving the same side either 
arm, face and leg. 
B.    Anterior Circulation Syndrome (partial) 
 It includes a moderate form of  stroke  involving MCA or 
         ACA  territory. 
 These people  will have 2  out of  3 criteria  of  
The total anterior circulation syndromes or involving       
Cerebral  dysfunction only or  both  motor /sensory defect  
confined  than those  defined as total anterior  circulation  
syndrome                    
C.   Lacunar Syndrome  
 includes  a subcortical stroke due to the occlusion of 
penetrating vessel  
 involvement of either higher mental function or loss of 
consciousness rules out lacunar stroke. 
D.  Posterior Circulation Syndrome 
 involvement of same side cranial nerve palsies and opposite 
side motor and sensory defects. 
 Motor and sensory defects of both the sides. 
 Defects in conjugate eye movements with cerebral 
dysfunction not involving the pyramidal tract of the same 
side. 
 Isolated homonymous visual field defects.  
 
 
 2  Hachinske  and Norris classification  
      A.     presumed stoke 
               Presumed TIA 
      B.     Anatomic classification 
                   a.           By vascular supply      -   Carotid 
                                                            Vertebrobasilar  
b. By location  
Supratentorial          lobar 
                                                    Ganglionic/thalamic 
       Infratentorial                    Cerebellar   
     Brain stem 
 
      C.   Etiological classification: 
             a.          By result   
 Cerebral Infarct   -                       Arterial 
                                                     Arteriolar 
                                                     Venous 
 Cerebral haemorrhage-                Parenchymal  
                                                     Subarachnoid 
                   b.     By cause  
 Ischemia               -                       Embolism  
                                                      Extra cranial 
vascular disease 
 Haemorrhage     -                         Hypertension  
Amyloid 
Angiopathy 
Vascular 
malformation                    
Aneurysm     
 EPIDEMIOLOGY 
               Stroke is one of the leading cause of morbidity in adults 
worldwide. The morbidity and mortality associated with stroke are  
Global.  
 400-800 strokes per 1oo,ooo 
 5.7 million deaths 
 16 million new acute stroke every year 
 Disability adjusted life year (DALYS) around 28 lakhs 
  4 week case fatality rate  ranges from 18% - 36% 
INDIA 
 Prevalence 90- 222 per 100,000 
 102,620 million deaths. 
 In each year the incidence of strokes cases were 1.4 to 1.6 
million 
 6,398,000 DALYs 
 The incidence of stroke below 40 years were around 12%. 
 4 week  case fatality rate ranges from 17%- 36% 
THE INCICENCE AND PREVALENCE OF STROKE IN 
INDIA 
                The datas of stroke were more restricted and  confined to  
 frequent bias in sample size and vague  eligibility criteria. But 
prevalence rate conducted at 2004 by Gourie devi at Karnataka was  
Urban  –  136 per 100,000 
Rural  -  165 per 100,000 
          The annual stroke occurrence  in india by sridharan (2009) at 
Trivandrum 
Urban  –  116 per 100,000 
   Rural  –  124 per 100,00  
by Bhattacharya (2005) at west Bengal. 
 
 
 
 
 
RISK FACTORS FOR STROKE 
1. Age :  
It is one of the strongest risk factor for stroke. It found to be 
25 times more common in people aged 75- 85 years than in people 
aged 45- 55 years. 
2. Gender:  
There is marginal rise of male preponderance in middle and 
old age. 
3. Blood pressure :  
Hypertensive patients are strongly associated with stroke  risk  
it correlates with both the systolic and diastolic BP. There is a 
relative  risk of cerebrovascular disease in hypertension both in 
men and women. 
4. Smoking: 
 There is a definite risk for  stroke . It has been established 
that  there is a dose – response relationship, affecting both sexes in 
all age groups .  
 
 5.Serum lipids : 
 There is a relationship between serum lipoprotein (a) 
6. Diabetes Mellitus:  
Patients with diabetes have twice the risk for acquiring the 
stroke when compared to non diabetic individuals. Stroke in 
diabetics will be very fatal. 
7. Hypercoagulable  states:  
Increased fibrinogen, increased plasma factor VII coagulant 
activity, decreased fibrinolytic activity, raised von Willebrand 
factor and raised haematocrit are all risk factors for stroke. 
8. Atrial fibrillation  
          Is one of the most common cause of cardio-embolic s strokes 
when particularly with patients associated with 
diabetes,hypertension,smoking, h/o previous peripheral vascular 
diseases. 
9. Alcohol : 
 Moderate consumption of alcohol may be protective for 
ischemic   stroke . But it also raises the blood pressure, alters lipid 
profile, increases the chance of AF and cardiomyopathy which may 
increase the risk of stroke. 
10. Diet: 
  Omega 3 fatty acids and unsaturated fatty acids in take may 
reduce stroke risk. Increase in salt in  take  increases blood pressure 
and stroke risk. 
11. Vascular disease: 
 Coronary artery disease, asymptomatic peripheral vascular 
disease and TIA are all associated with increased stroke risk. 
12. Hereditary factors:   
Connective tissue disorders such as Marfans syndrome, 
MVP, Fibromuscular dysplasia, Pseudoxanthoma elasticum,  
Ehlers- danlos syndrome, haematological disorders like protein  C 
deficiency, dysfibrogenamia,  antithrombin III deficiency,  sickle 
cell  disease, familial hypercholesterolemia, homcysteinemia,  
cardiac myxoma,  Fabrys disease are linked with higher  risk for 
stroke. 
 
ETIOLOGY OF ISCHEMIC STROKE 
              COMMON                                 UNCOMMON 
Thrombosis Hypercoagulable 
disorders 
Lacunar stroke Protein S deficiency 
Large vessel thrombosis Factor V leiden 
Dehydration Antithrombin deficiency 
Embolic occlusion Antiphospholipid 
syndrome 
Artery-to- artery Protein C deficiency 
Arterial dissection Systemic malignancy 
Carotid bifurcation Sickle cell anaemia 
Aortic arch Prothrombin G 20210 
Mutation 
Cardioembolic Polycythemia vera 
Atrial fibrillation Homocysteinemia 
Mural thrombosis Thrombocytopenic purpura 
Dilated cardiomyopathy Systemic lupus 
erythematousus 
Myocardial infarction Beta Thalssemia 
Valvular lesions Dysproteinemias 
Mitral stenosis Oral contraceptives 
Mechanical valve Nephrotic syndrome 
Infective  endocarditis Inflammatory bowel 
disease 
Paradoxical embolism Disseminated 
Intravascularcoagulation 
Atrial septal aneurysm Venous sinus thrombosis 
Spontaneous ECHO contrast FIbromuscular dysplasia 
 Vasculitis 
 Primary CNS vasculitis 
 Sytemic vasculitis(PAN, 
Wegener’s,Takayusu,s 
Giant cell arteritis) 
Meningitis ( Syphilis, 
fungal , Herpes  Zoster) 
Cardiogenic 
Mitral valve calcification 
Itracardiac tumour 
Atrial myxomas 
Libman ‘s sacks 
endocarditis 
Subarchnoid haemorrhage 
vasopasm 
Drugs- cocaine, 
amphetamine 
Eclampsia 
Moyamoya disease 
         
Pathophysiology of stroke: 
                          More than any other organ, the brain depends from 
moment to moment on an adequate supply of oxygenated blood .  
Cerebral infarction comprises of mainly two pathological processes 
one a loss in the supply of  oxygen and glucose secondary to 
vascular occlusion and the other an array of changes in the cellular 
metabolism consequent o collapse of energy producing processes , 
ultimately with the disintegration of cell structures and their 
membranes ,a process termed as apoptosis. Some cellular processes 
leading to neuronal death and are not irrevocable and may be 
reversed by early intervention of restoration of blood flow 
 
ISCHEMIC CASCADE 
A significant fall in the cerebral blood flow produce cascade of 
events which if unchecked lead to the production and accumulation 
of toxic compounds and apoptosis (programmed cell death) 
 
 
                      Mismatch between CBF and metabolic demands 
                    (O2- glucose) 
 
 Electrical  failure                                                             Aaerobic  
Ionic pump failure                                                           metabolism 
K + efflux , Na+ influx 
           Ca+ influx 
         Stimulates                                                       Lactic acidosis 
 membrane phospholipids  
Arachnoidic acid  
Cyclo oxygenase                                Lipo oxygenase 
Prostaglandins  
 
 
TXA2                    PG                       PGI2 
 
 leucotrines 
 
Potent 
vasoconstrictor 
and antiplatelet 
aggregant 
Other  
prostaglan
dins 
potent 
vasodilator 
and platelet 
anti 
aggregant 
NEURONAL 
DAMAGE 
 
 
 Role of neurotransmitters  
          In addition to the cascade outlined above one of the amino 
acid excitatory neurotransmitters, Glutamate in excess is a powerful 
neurotoxin which plays a important role in ischemic brain damage. 
Approach to stroke patients 
 The rapid evaluation of patients presenting with stroke is important 
as it may  leads to  prompt treatment such as thrombolysis 
 An adequate history from an attenders is essential 
 Once provisional diagonosis is made , brain imaging study is 
essential to determine whether the etiology is ischemic or 
haemorrhagic. 
INVESTIGATION 
1. CT SCAN : 
  It identifies  or exclude the haemorrhage as the cause of 
stroke . It helps to identify extraparenchymal haemorrhages, 
neoplasms, abscess, and other conditioning masquerading the 
stroke. 
 
2. MRI : 
This clearly shows the exact size of the infarcted areas of the 
brain which includes the cortex and posterior fossa. Diffusion 
weighted imaging is more sensitive for early brain infarction than 
standard MR sequence or CT. 
3. MRI arteriography  
 is the confirmatory investigation for detecting   stenoses of 
cerebral arteries and diagnosing and detecting  pathologies such as 
aneurysmal dilation, vasospasms, fibromuscular dysplasias, 
vascular causes,  intramural thrombi, arteriovenous fistula and 
collateral channels of blood flow. 
   4.Ultrasound technique: 
 Stenosis at the origin of the internal carotid artery can be 
identified and characterizied by  Duplex ultrasound . Transcranial 
Doppler can assist in thrombolysis and improve large artery 
recanalization  following  rtPA administration. 
 
 
5. Perfusion techniques: 
 MR perfusion can be MR diffusion imaging is to identify the 
ischemic penumbra as the mismatch between the two images .The 
ability to image ischemic penumbra helps more judicious use 
selection of patients who may or may not benefit from acute 
interventions such as thrombolysis, thrombectomy or other 
investigational purposes. 
6. Echocardiogram:  
To identify any cardiac source of embolism. 
 
TREATMENT:  
1. Medical support 
         - securing the airway to protect from aspiration and 
hypoventilation. 
         -  blood pressure should be lowered if there is malignant 
hypertension or concomitant myocardial ischemia or if blood 
pressure is  more than  180/110mm hg and thrombolytic therapy is 
anticipated. 
         - if brain oedema is seen then  it can be reduced  with 
mannitol           
- maintainence of body temperature to prevent hyperthermia  
         - Blood glucose should be monitored and maintained at 
110mg/dl, if necessary by using insulin infusion. 
2. Thrombolysis  
           Administer IV rtPA 0.9 mg /kg (max 90mg) 10% given as 
bolus and the remaining dose within 1 hour.       
 
 
 
 
 
 
 
 
 
INDICATION AND CONTRAINDICATION FOR 
THROMBOLYSIS 
INDICATION CONTRAINDICATION 
 Clinical diagnosis of stroke  
 Onset of symptoms to the 
time of drug administration 
within 3 hours. 
 CT scan showing no 
haemorrhage or edema of > 
1/3 of MCA territory  
 Age > 18 years 
 Consent by patient or 
surrogate 
 Sustained BP . 185/110 mmhg  
despite treatment 
 Platelet < 100,000, HCT < 25%, 
blood glucose < 50 or >400 g/dl  
 Use of heparin within 48 hrs and 
prolonged PTT and elevated INR 
 Rapidly improving symptoms 
 Prior stroke or head injury within 
3 months, prior intracranial  
Haemorrhage 
 patients undergone surgery within 
2 weeks 
 symptoms of mild stroke 
 Any bleeding from GIT within 2 
weeks deeply comatose and 
stuporous or patients suffered 
from recent myocardial 
infarction. 
 
  
 
4. Antiplatelet: 
    Aspirin within 48 hours of stroke occurred decreases both           
recurrence of stroke and death minimally. Aspirin, clopidogrel and 
combination of aspirin and dipyridamole are used. 
5. Anticoagulation: 
    There are many trials have fail to prove the benefit from 
anticoagulation. But there are indications in conditions such as 
carotid artery bidissection, Basilar artery thrombosis, cardio 
embolic stroke. 
6. Neuroprotection : 
 It is the concept of providing a treatment that prolong brain 
tolerance to ischemia. 
7. Stroke centres and rehabilitation: 
  Team that provide emergency 24  hour  evaluation of acute 
stroke patients for acute medical management , thrombolysis and 
endovascular treatment which are essential ingredients of primary 
and comprehensive stroke centre . It also include early physical, 
occupational speech therapy. 
THE PROGNOSIS OF ACUTE STROKE 
      The outcome of an individual who had recovered from stroke 
depends on certain factors  
1. Age :  
The survival is better in younger than the older people, more 
in men than in women  
2. Comorbid conditions: 
  There are factors such as diabetes, dyslipidemia, 
hypertension, atrial fibrillation, smoking, alcohol, previous h/o 
stroke leads to recurrent stroke and also influence on outcome and 
survival of the individual. Other diseases such as COPD,  
Parkinsons disease, peripheral vascular disease, polyneuro- 
pathy have effect on functional recovery. 
Lesion related factors 
             Survival is poor in anterior circulation infarcts than 
intracerebral or subarachnoid haemorrhage. Coma at onset of stroke 
makes is an important predictor of 4 weeks survival. There are  
symptoms such as seizures, brain  stem dysfunction, B/L pyramidal 
signs carries an high.er risk of mortality. 
3. Specific therapy 
         Good supportive care such as cardiac and respiratory support 
may  reduce the mortality. 
 4. Biochemical factors: 
         Recent studies suggests that microalbuminuria has been  
associated with poor outcome. Lipoprotein (a) found to be 
independent risk factors for vascular diseases. Higher blood 
glucose at the onset of stroke even in non diabetic individuals 
predict the poor survival. 
STROKE SCALES 
Acute assessment stroke scales  
1.  Canadian neurological scale  
2.  European stroke scale 
3.  Glasgow coma scale 
4.  Hemispheric stroke scale  
5.  National institute of health stroke scale 
 Functional assessment scale 
1. Modified  Rankins  scale  
2. Barthel index 
3. Glasgow outcome scale 
4. Berg balance   
 NATIONAL INSTITUTES OF HEALTH STROKE 
SCALE 
LEVEL           SCORE 
stages of consciousness                                                
          Conscious                   0  point 
          somnolent                                                                     1 point 
          patient responds to deep painful stimuli                  2 points                                              
deeply comatose                                                 3 points 
orientatation 
          tells about his age and date                                 0 points 
          able to answer one question perfectly                          1 point 
          not able to answer any question  properly               2 points 
 response to verbal 
         obeys 2 verbal speech                               0 points 
         obeys 1 verbal speech                                                   1 point  
         not obeying  to any verbal speech                                2 points 
movement of eyes  
        perfect  movement of both the eyes                               0 points 
        moderatere  paresis to 1 one side                            1 point 
        severe  gaze  palsy to 1 side                                           2 points 
visual impairment 
       Normal vision                                                               0 points 
        homonymous  hemianopia (moderate)                          1 point 
       homonymous  hemianopia   (total)                                 2 points 
       total  visual impairment                                                  3 points 
motor  function ( face) 
        Normal face                                                                   0 points 
       Minimal one sided facial palsy                                      1 point  
        Moderate  one sided facial palsy                                   2 points 
        total  facial palsy either 1 or 2 sides                             3 points 
motor  function of the upper limb ( scores 8 points) 
     no  paralysis                                                                0 points 
         slight  decrease  in movement in upper limb              1 point 
         minimal strength against gravity                                  2 points 
         moderate strength  against gravity but moves limbs      3 points 
         complete paralysis                                                         4 points 
 motor function of the lower limbs ( score  8 points)  
        no paralysis                                                                   0 points  
          slight paralysis of lower limb                                       1 point 
          moderate paralysis  against gravity                              2 points 
         moderate strength against gravity but moves             3 points 
  the limb 
         complete paralysis                                                         4 points 
ataxia of limb ( not in presence of paralysis) 
         normal ataxia                                                                 0 points  
         present in 1 limb                                                           1 point 
         present in   2 limbs                                                      2 points 
sensory modalities  
         normal                                                                          0 points 
        sensory loss from minimal to moderate                       1 point 
        sensory loss is complete                                               2 points 
speech 
           speech is normal                                                        0 points 
           minimal to moderate speech impairment                 1 point 
           speech impairment  is severe                                    2 points 
           speech loss is complete                                            3 points 
Articulation 
           Normal                                                                      0 points 
           Minimal to moderate articulation impairment          1 point 
           Severe articulation impairment                                2 points            
Neglect 
           normal                                                                      0 points 
           minimal to moderate visual or sensory neglect      1 point 
            severe  visual and sensory neglect          2 points 
 
MODIFIED RANKINS SCALE 
SCORE               SEVERITY OF FUNCTIONAL LOSS 
1    normal 
2                                   symptoms present but no impairment                    
3                                   minimal impairment with no assistance  
                                      required 
4                                   impairment is moderate but can move 
5                                   severe impairment 
6                                   expired 
              
MICROALBUMINURIA 
DEFINITION 
                   Microalbuminuria defined as the range in between 
urinary excretion of albumin of 20 – 200 µg/min or 30- 300mg/24 
hours.  The low- normal albuminuria is defined as a morning 
excretion less than 10mg/l. High normal albuminuria is in between 
10 – 20mg/l. 
MECHANISM  
               The   correlation between the microalbuminuria and 
vascular permeability leads to higher sensitivity during any 
inflammatory process such as cerebrovascular disease. 
              Any small changes in the vascular gets amplified by the 
kidney. Overall kidney receives ¼ the of cardiac output. The 
amount of albumin that enters t the kidney all through out the day is  
70 kg. The glomerular filtrate that reaches the renal tubules is 7g/24 
hr. Most of the albumin taken up by the proximal tubule taken up 
by the mechanism such as high affinity low capacity endocytotic 
process leading to only 10-30mg/24hr appears in the urine. The 
amount of albumin filtered over 24 hours is 7 gm . If 1% change in 
the systemic vascular permeability due to inflammatory stimulus 
would lead to extra 70 mg of albumin during the filtration process. 
Since tubular mechanism for reabsorption of albumin were near 
saturation would lead to change in the albumin excretion from 
range of 30 mg / hr to more than 100 mg/ hr. 
        Both charge and size selectivity are properties of 
endothelium. The negative charge is confined to glomerular 
membrane by its consistent glycoprotein plays a major role in 
restricting the permeability of anionic proteins. So the loss of 
charge selectivity in the glomerulus leads to microalbuminuria not 
only in diabetic individuals  but also  in  non diabetic individuals.  
 
Other mechanisms of microalbuminuria as follows  
1. Impaired arterial dilatory capacity:   
In clinically normal individuals slight increase in albuminuria 
excretion leads to impaired dilatation of arteries. This decrease in 
arterial dilatory response was seen in both in vivo and in vitro. This 
reduced arterial dilatory capacity may lead to higher cardiovascular 
risk in subjects with increased urinary albumin excretion. 
2. Hyperhomocysteinemia:  
This is seen as a major risk factor for atherosclerosis. The 
patients who are associated with hyperhomocysteinemia leads to 
higher risk of cardiac and cerebrovascular disease. 
3. Sytemic Transvascular albumin leakage;  
In vivo the rate of transcapillary escape of albumin is an 
overall measurement of vascular permeability. Transcapillary rate 
of albumin is defined as the fraction of the intravascular mass of 
albumin going through the vascular bed per unit time. Hence 
microalbuminuria directly proportional to transvascular leakiness 
of albumin which in turn may allow more amount lipid insudation 
into the larger arteries leads association of microalbuminuria to 
atherogenesis. 
4. Hyperinsulinemia:  
Hyperinsulinemia  and Microalbuminuria are the two major 
factors of metabolic syndrome. There are studies shows that insulin 
may cause smooth muscle cell proliferation which in turn 
accelerate the LDL binding in smooth muscle cells and cholesterol 
synthesis in monocytes. 
5. Role of sialic acid:  
There are studies that reveals sialic acid influence many 
haematological factors, deposition of lipids in the arteries and 
transvascular permeability. The higher level of serum sialic acid 
acts as a predictive value of atherosclerotic vascular disease in 
patients especially without diabetes mellitus with an elevated 
urinary albumin excretion. 
6. The elevated VWF concentration and prothrombotic factors:  
There are many studies that shows prothrombotic factors 
such as vWF, factor VIIc, and fibrinogen are higher in patients with 
type 1 DM as well as hypertensive patients who are associated with 
microalbuminuria.  
 
 
 
 
  
SIGNIFICANCE OF MICROALBUMINURIA 
          The importance of microalbuminuria indicates different 
vascular permeability and its  diagnosis shows  not only renal 
disease but also higher risk of cerebrovascular diseases.  There 
were two landmark studies in the early 80’s which showed the 
importance of microalbuminuria and independently predict the 
development of nephropathy in diabetic individuals and increasing 
renal  impairment. Therefore, different studies were conducted to 
highlight the importance of microalbuminuria in various 
conditions:  
 
 
 
 
 
 
  
ADA guidelines for Diabetic Nephropathy 
Stages Albuminuria 
cut –off values 
Clinical characters 
Micro 
albuminuria 
20-199 
mcg/min 
Abnormal nocturnal fall in BP and rise in BP 
level 
 30-200  
mcg/24 hrs 
Increased Triglyceride, total and LDL 
cholesterol. 
Higher incidence  of metabolic syndrome 
component.  
  Endothelial dysfunction. 
   Linked with retinopathy of diabetic 
individuals  and amputation and CVD 
Micro 
albuminuria 
>200 mcg/min Hypertension  
 >300 mcg/24 
hr 
Increased triglycerides, total and LDL 
cholesterol. 
 >300 mg/gm Asymptomatic Myocardial ischemia 
  Progressive GFR decline 
 
ADA  recommended  microalbuminuria as a risk factor for 
cardiovascular  diseases in patients with diabetes. 
 2.  Studies have shown that the prevalence of microalbuminuria 
is enhanced in hypertensive subjects, in particular in those with 
blood pressure characteristics that are associated with enhanced 
cardiovascular risk, such as salt sensitivity and an abnormal diurnal 
blood pressure rhythm. Microalbuminuria  possibly identifies  at an 
early stage, hypertensive patients with an elevated  risk of 
developing the well-known cardiovascular  and  renal  hypertensive 
complications. 
3.  There are many studies that have  shown  the association   of 
microalbuminuria and  risk factors for atherosclerosis such as 
diabetes hypertension and dyslipidemia in the normal  population. 
Studies have  shown that the importance of microalbuminuria as 
predicts  more mortality among the patients aged more than  70 
years. 
4. Microalbuminuria is detected in earlier stage of Acute 
Myocardial Infarction and is considered as an independent factor 
that  predicts  of early mortality. Microalbuminuria had  been found 
to be directly  proportional to the size of the infarct.   
5.      There is one study shown that microalbuminuria  
distinguished aseptic meningitis  from bacterial meningitis 
with specificity of 94%- Roine et al 
6.  One study  had shown  that  microalbuminuria  significance  
Predicting a   of  36  months  prognosis  in patients who had 
suffered from acute coronary artery disease - Spyridon  k et al 
7.  There are studies that has  shown  early rise in urinary 
albumin concentration is useful in differentiating between  
myocardial infarct from Angina- Gosling et al 
8.  Microalbuminuria  had  been found to be associated with 
wide variety of inflammatory conditions like, surgery, 
rheumatoid arthritis, inflammatory disorder 
9. There  was a significant correlation  between carotid artery 
thickness and microalbuminuria which reveals that 
microalbuminuria  may be a significant marker in the 
development of atherosclerosis in carotid artery  which 
indicates a possible linkage between atherothrombotic stroke 
and microalbuminuria. 
10.  Shearman et al found that microalbuminuria peaked in 36 
hours after admission in individuals with acute pancreatitis 
and that has serious complications developed later only those 
with higher values of microalbuminuria . 
11.    Pallister et al found that microalbuminuria levels after 8 hours 
of admission in trauma victims predicted the development of 
ARDS with appositive predictive value of 85% and negative 
predictive value 95%. 
STUDIES RELATING MICROALBUMINURIA and 
ISCHAEMIC STROKE 
              Eventhough microalbuminuria is associated with risk 
factors of cerebrovascular disease including  hypertension, previous 
h/o myocardial  infarction, diabetes, aging and left ventricular 
hypertrophy but there are few data regarding microalbuminuria 
predicting independent risk factor for stroke . There are several 
studies that has been done and proved association of ischemic 
stroke and microalbuminuria. 
1. Damsgaard  EM et al followed 216 people who had been 
selected as control subjects for diabetics during a sytemic 
screening for diabetes mellitus among all people aged between 
60-75 years living in municipality of Fredericia, Denmark 
between Feb 1981 and Dec 1987. Their clinical and biochemical 
examination were found median urinary excretion rate of 
albumin is 7.53mcg/min. 8 of those rate below median died 
compared to 23 with a rate equal to or greater than the median. 
The median albumin excretion rate is the 31 who died was 15 
mcg/min and cardiovascular disease was the main cause of death 
in both groups.  
2. Yudhkin et al used Islington Diabetes survey in 1988 to study 
urine albumin excretion and found that urinary albumin 
excretion had skewed distribution with maximum rate of 191.9 
mcg/min . There was significant correlation between albumin 
excretion rate and systolic BP, diasolic BP and 2 hour blood 
glucose but not with age , sex or BMI. 
3. Mlack B et al studied the frequency of microalbuminuria in 
patients with and without diabetes (138/160) randomly selected 
from a stratified sample comparable with known diabetes by 
age, sex and profession in metlika county, Slovenia between 
1994-1998. The groups were examined in the same way and 
mortality was followed over 5 years. Albuminuria was 
significantly high in diabetes , hypertension, coronary artery 
disease, dyslipidemia, peripheral vascular disease. The 
albuminuria was frequent in those who died in the observed 5 
year period. 
4.  Heikke Meiettinen et al had shown that study conducted 
during 1982 and 1990 had found increased excretion of urinary 
albumin in 25 % of non diabetics and 58% of NIDDM subjects . 
The morbidity and mortality were more in patients both in NIDDM 
and non diabetic patients with albuminuria  than in those patients 
without albuminuria  
5.  Nancy B. Beamer et all had shown in that study done in 
Oregan Health sciences university Hosspital in Portland conducted 
around 1999 found that microalbuminuria seen in in acute ischemic 
CVA individuals three times more than in individuals with risk 
factors and not detected in healthy individuals .On follow up period 
of 1.5 ±0.9 years 1/5 th   of patients with ischemic CVA  14% were 
with risk factors for stroke is 0% in healthy individual volunteers 
had vascular end points with events being as frequent in patients 
with microalbuminuria (32%) as in patients without 
microalbuminuria . 
6.  Yuyun MF et al had conducted population based on cohart 
study in Britain among 23,630 subjects between 40- 79 years and 
followed up for 7 years ( 93 – 97) with  albuminuria tested. There 
are 246 strokes were occurred. Then age adjusted incidence of 
stroke elevated significantly among all catagories of baseline 
albuminuria. So they had identified that microalbuminuria 
independently associated with 50% increased risk of stroke in 
general population. 
7. Hans.L .Hillege et al had done study in Groningen , 
Netherlands around 2001 and had found that elevated levels of 
microalbuminuria more frequent with aging, male sex , smoking, 
hyperlipidemia, hypertension, diabetes. Eventhough Micro and 
macroalbuminuria were found more in diabetic and hypertensive 
patients that are independently associated with cardiovascular risk 
factors. 
8.  Turaj et al had shown on a study on 52 patients in 
Jagiellonian university Caracow, Poland within 24 hours after 
stroke. Microalbuminuria were found in 24 out of 52 stroke patients 
( 46.1% ) and 5 out of 37 controls ( 13.5%) ( p <0.05) . Then 3 
months mortality was more in subjects with micro albuminuria than 
when compared to subjects without  micro albuminuria ( 45.8% vs 
7.1%). The individuals with micro albuminuria scored lesser scores 
in Scandinavian stroke scale than in individuals without 
microalbuminuria both at the time of admission and later. 
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Treatment of microalbuminuria  
1. Control of hypertension  
         Studies have shown secondary prevention of hypertension 
effectively decreases albuminuria. The treatment of choice was 
Angiotensin converting enzyme inhibitors and Angiotensin 
receptor blocker for controlling microalbuminuria. The cut off 
point for blood pressure should be <130/80 mm hg for diabetics 
and < 140/90 mm hg for non diabetic individuals.  
 2. Control of blood glucose  
        Aggressive diabetic control effectively decreases the risk of 
developing microalbuminuria in patients especially with diabetic 
individual. 
3. Treatment of hyperlipidemia  
          The use of statins has many indication such as to modify 
thrombus formation, plaque stabilization, inflammatory response, 
endothelial dysfunction. It also has effective reduction of 
microalbuminuria. 
 
4. Protein restriction  
        The normal intake of protein is 0.8g/kg/d.in patients with renal 
diseases. There are studies that shown restriction of protein intake 
decreases hyperfiltration and intraglomerular pressure there by 
reducing the progression of microalbuminuria. 
5. Smoking  
         Smoking should be stopped in patients as it not only 
protective against cardiovascular disease but also decreases the 
progression of microalbuminuria 
 
TESTS FOR MICROALBUMINURIA 
         The albumin in the urine is one of the risk factors for 
cardiovascular and cerebrovascular diseases. Hence the detection of 
albumin in the urine depends on the tests to identify 
microalbuminuria. Traditional qualitative tests cannot detect small 
quantities of albumin in the urine.  The various methods are as 
follows 
 
Dipstick method 
             Chemically impregnated dipstick contain methylred and 
bromophenol blue buffering salts . The later dissolve on contact 
with urine and protein in the urine lowers pH turning it green . It 
was traditionally known to detect albuminuria > 300mg /dl . hence 
not advocated for screening of microalbuminuria  
1. Semiquantative analysis: 
Chemical precipitation test : 
                         5 drops of 20% sulphosalicyclic acid is added to 3 
ml of urine in one test tube . This test tube is compared to test tube 
of untreated urine held against the dark background immediately 
and turbidity is taken to indicate proteinuria  
Immunoprecipitation test : 
Micral test :  
                  It is based on color shift on monoclonal antibody in 
human albumin labeled with gold. Here gold labeled antibody 
optically read immunoassay detects microalbuminuria. A specimen 
of the urine sample pass via wick fleece into the conjugate fleece. 
Any albumin present in the urine binds itself specifically to the 
gold labeled antibodies. Excess antibodies are bound by 
immobilized albumin in the capture matrix .only antibodies bound 
to albumin for capture matrix the urine sample and pass through   
 Lapiuex agglutination tests (inhibin test): titre is adapted in away 
that drop of antihuman albumin falls one by one and attach all 
connection places of albumin in urine in concentration over 30mg /l 
and more. 
2. Quantitative analysis:  
           There are many reactions for measuring albumin 
concentration in urine but all of them use the same principle 
;immunochemical reaction between antibody to antihuman albumin 
and albumin. Difference is only the preparing the reaction, Elisa, 
immunoturbidimetry,Nephalometry and Electrochemiluminescence  
RIA. 
All these methods are mostly well balanced and good 
analytical precision, sensitivity and detection area.  A quantitative 
procedure can be done by using immunological test methods on 
standard automated analyzer. 
Radioimmunoassay 
                         It is one of the gold standard for estimation of 
microalbuminuria. It is the double antibody technique where 
albumin the sample has to compare with the fixed amount of 125I 
labeled albumin for the building sites of specific antibodies. Bound 
and free albumin is separated by separated addition of a second 
antibody immnuoabsorbent followed by configuration and 
decanting . The radioactivityin the pellet is measured a C- counter . 
Albumin concentration with sample inversely proportional to 
radioactivity . The sensitivity RIA method was 0.3 mg/ml. 
Microalbumin – turbidimetric           
 Estimation of microalbumin in urine  in our case is done by 
Latex turbidimetric  
PRINCIPLE  :  
1. Its a slide agglutination tests  
2. It depends on the turbidity of the solution  
3. The albumin in a sample of urine gets reacts with specific antibody 
coated with latex particles. The turbidity measured with a 
spectrophotometer and its absorbency is proportional to albumin 
concentration  
Material required :  
Thermostatic bath at 37c Spectrometer or thermostable at 37 
c with a 540 ±20 nm filter. 
Procedure:   
The working reagent is warmed  and the photometer to 37 
1. Mix well and record the absorbances immediately (A1) and 2 
minutes (A2) after the sample addition  this gives the final result on 
microalbuminuria. 
 
 
 
 
 
 
 
 
 
 
 
METHODOLOGY 
Source of data  
       The patients admitted both in the department of 
medicine and department of Neurology in Government Rajaji 
Hospital affiliated to Madurai medical college between January 
2012 to May 2012 were taken in our study. Ethical committee 
approval was obtained                   
Collection of datas 
1. Prospective observational study  
2. There were 50 patients enrolled in the study diagnosed and 
clinically confirmed by CT Scan brain  
Inclusion criteria  
1. Patients were diagnosed as stroke according to WHO 
criteria which includes patients of any age and both sexes 
within 48 hours  onset of symptoms. 
2. Ischemic infarct confirmed by CT scan  
3. Informed consent obtained from the patient  
 
Exclusion criteria 
1. Patients with haemorrhagic stroke 
2. Patients with diabetes who is on antidiabetics or Fasting blood 
glucose > 126mg/dl or Random blood glucose > 200 mg /dl  
3. Any abnormal urinalysis  
4. Patients who are on antihypertensives or with cut off value for 
blood pressure > 140mm hg  in systolic and >90 mm hg  in 
diastolic.  
    Patients were taken detailed history,  proper clinical 
examination and required laboratory investigations done.  
   The severity of the stroke scale were assessed using NIHSS 
and functional assessment were done by using mRs. 
In the above patients following investigation were done as 
follows  
1.  CT scan were done to confirm ischemic infarct. 
2.  urinalysis were done to exclude proteinuria, leucocyturia, 
haematuria, glucosuria. 
3.  Cardiac evaluation were done using ecg, echo and chest x 
ray. The albumin excretion was assessed by using 
turbidimetry tests in the urine sample. spot sample obtained . 
microalbuminuria is defined such as urinary albumin 
excretion between 20- 200 mg dl.  
4.  After the patients gets discharged from the hospital subjects 
were again tested 6 weeks later to determine the outcome of 
the stroke including the mortality by functional assessment 
scales using Modified Rankins scales.  
5.  50 age and sex matched controls were selected among the 
subjects with > 6 months old who had suffered from stroke 
and were coming for follow up . 
6.  The control subjects were tested for risk factors for stroke 
and estimate the presence of microalbuminuria using latex 
turbidimetry tests, plasma glucose, lipid profile 
 
 
 
 
 
RESULTS AND OBSERVATION 
Study design  
         Our study was done comparing 50 recent ischemic stroke 
patients as cases and as 50 old stroke patients as controls  and  
showed the  following findings . 
TABLE 1 
AGE DISTRIBUTION 
Age in years Cases Controls 
<40 6 1 
41-60 25 34 
>60 19 15 
Total 50 50 
Mean 55.80 55.82 
SD 12.79 9.83 
p value 0.998 Not significant 
 
 
TABLE-2 
Age distribution by microalbuminuria 
Age in years < 20 20- 200 
< 40 3 3 
41-60 15 10 
>60 12 7 
Total 30 20 
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The youngest patient among the cases was 18 years and 
oldest was 78 years. The youngest patient was among controls was 
39 years and old patient was 80 years.  
 
The mean age cases were 55.80±12.79 and in controls were 
55.89±9.83 there is not much difference in age. The majority of the 
cases and controls were found in the age group of 41-60 years of 
age .  The age is not statistically significant as p= 0.998 
 
TABLE-3 
Sex distribution  
Sex Cases Control 
Male 32 35 
Female 18 15 
Total 50 50 
 
 
 
 
 
 
Table - 4 
Sex distribution by microalbuminuria 
Sex <20 20-200 
Male 18 14 
Female 12 6 
Total 30 20 
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As such there is no more difference in the sex distribution 
between male and female Incidence of stroke were more in males 
than females but that was not statistically  significant 
Table – 5 
Duration  of Symptoms in hours 
Duration  of 
Symptoms in hours 
No of cases Percentage 
< 8 1 2 
9-24 33 66 
24-48 15 30 
>48 1 2 
Total 50 100 
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DURATION OF SYMPTOMS
No.of cases Percentage
 
In our study  in cases majority of the subjects had duration of 
symptoms within 9-24 hours is 33(66%) where as 15 patients had 
symptoms within 24-48 hours ( 30%) and more than 48 hours only 
1% had presented with symptom 
Table -6 
Paucity of movements 
Paucity 
 
No of cases percentage 
Left 20 40 
Right 26 52 
None 4 8 
Total 50 100 
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     Among the case 20(40%) were had  left sided hemiparesis and 
26(52%) were had right sided hemiparesis  and 4(8%) had no focal 
neurological deficit. 
 
Table – 7 
Microalbuminuria 
Microalbuminuria Cases Control 
<20 30 43 
20-200 20 7 
Total 50 50 
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Inference:   The patients with recent ischemic stroke were 2.578 
times more likely to have microalbuminuria  with p= 0.0447. 
        Microalbuminuria were found in 20 (40%) patients with recent 
ischemic stroke where as 7(14%) . Therefore patients with recent 
ischemic stroke were 2.58 times high likely to have 
microalbuminuria as compared to controls. 
TABLE- 8 
Presenting factors associated with microalbuminuria 
Presenting 
factors 
<20(30) 20-200(20) P - value percentage 
LOC 8 17 0.041 50 
HEADACHE 0 0 0.100 0 
SEIZURES 0 6 0.019 12 
APHASIA 8 17 0.041 50 
VOMITING 0 0 0.100 0 
GIDDINESS 2 0 0.690 4 
SMOKING 1 8 0.019 18 
ALCOHOL 2 8 0.083 20 
H/O PVE 1 7 0.034 16 
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Among the presenting factors  loss of consciousness, 
seizures, aphasia, smoking, h/o previous vascular diseases were 
higher among the cases than the controls and also statistically 
significant. Hence this implies that microalbuminuria corrlates with 
the severity of the stroke. 
 
 
 
 
 
 
Table – 9 
 Mean + SD ‘p’ value 
< 20  (30) 20 – 200  
(20) 
Cholesterol 196.6 ± 12.23 194.1 ± 15.06 0.516   NS 
HDL 45.3 ± 4.76 45.2 ± 4.22 0.910   NS 
LDL 105.5 ± 7.40 110.1± 9.01 0.057   NS 
Triglyceride 198.7 ± 10.28 196.5  ±5.42 0.378   NS 
 
Among the cases the Total cholesterol, HDL,  
Triglyceride  were lower among the patients with 
microalbuminuria and  LDL was higher but  it is not 
statistically significant. 
 
 
 
 Table  10 
Blood Pressure and Renal parameters 
 Mean + SD ‘p’ value 
< 20  (30) 20 – 200  (20) 
Systolic BP 119.0 ±13.22 120.4 ±12.61 0.710   NS 
Diastolic BP 79.0 ±10.62 82.0 ± 7.68 0.283   NS 
Urea 23.03 ± 3.61 22.40 ± 3.82 0.555   NS 
Creatinine 0.850 ± 0.104 0.875 ± 0.116 0.432   NS 
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Among the blood pressure diastolic blood pressure higher 
than the systolic pressure but it is not statistically significant . 
Renal parameters were not significant. 
TABLE-11 
Blood Sugar 
Blood 
sugar level 
< 20 (30) 20 – 200 (20) ‘p’ value 
< 100 12 19 0.906  Not significant 
> 100 8 11 0.908  Not Significant 
Total 20 30  
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The blood sugar in the stroke patients were not significant in 
patients both with and without microalbuminuria. 
TABLE- 12 
CT Scan results 
CT Scan results < 20 (30) 20 – 200 (20) Percentage (%) 
RACA 0 0 0 
LACA 0 0 O 
RMCA 13 6 38 
LMCA 13 6 38 
RPCA 0 3 6 
LPCA 2 2 8 
Combined 4 2 12 
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According to CT scan results predominant lesion were the middle 
cerebral artery infarct in study accounts to 38% each left and right 
sided lesions 
TABLE-13 
NIHSS score 
NIHSS < 20 (30) 20 – 200 (20) 
<  10 14 4 
11 – 20 10 3 
21 – 30 3 9 
> 30 3 4 
Total 30 20 
 
 
 
 
 
 
 
 
TABLE-15 
NIHSS score vs Microalbuminuria 
     NIHSS < 20 (30) 20 – 200 (20) ‘p’ value 
<  20 24 6 0.109  Not significant 
> 20 6 14 0.045  Significant 
Total 30 20  
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Severity of the stroke scale were measured using  NIHSS . 
The severity of the stroke scale were higher in patients with 
microalbuminuria and it was statistically significant 
TABLE-16 
Modified Rankins Scores 
mRS < 20 (30) 20 – 200 (20) ‘p’ value 
<  3 28 12 0.608  Not significant 
> 3 2 8 0.035  Significant 
Total 30 20  
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The functional assessment scale was done using Modified 
Rankins index patients with microalbuminuria were found higher 
scores which indicates patients with  microalbuminuria were found 
to have more neurological deficit than patients without 
microalbuminuria . 
DISCUSSION 
               Our study is a comparative study with 50 acute ischemic 
stroke subjects as cases and 50 old stroke subjects as controls were 
taken to  
1. To estimate the incidence of microalbuminuria in acute 
ischemic Stroke. 
2. The difference in various laboratory investigations done in 
subjects with and without  microalbuminuria. 
3. The correlation of National institute of health stroke scales 
and Modified  Rankins scale in presence of microalbuminuria 
Presence of microalbuminuria  
 Microalbuminria in 
cases 
Microalbuminuria in 
controls 
Beamer et al  29% 10% 
Slowik A et al  46.7% 16.7% 
Turaj et al  46.1% 16.7% 
Our study 40% 14% 
 
 In our present study we found that age and sex matched 
controls were having similar presenting and pre disposing factors , 
subjects with acute ischemic stroke  were 2.58 times more likely to 
present with microalbuminuria .The present study we found 40% of 
the patients with microalbuminuria had incidence of stroke and 
14% of patients were found in the controls. The above findings 
were found to be similar to the studies conducted by others such as 
Beamer et , Slowik et al and turaj et al. 
Age and microalbuminuria 
 
 
Microalbuminuria 
present 
Microalbuminuria 
absent 
Control 
Turaj et al  73.3±11.6 66.0±12.0 65.2±5.5 
Our study 55.80±12.79 55.82±9.83  
 
The studies such as Turaj et al had shown that age had 
influence on the neurological deficit. older the age severity of the 
deficit is increased, But in our study there is no correlation between 
the age and microalobuminuria  and was not statistically 
significant. 
Sex and microalbuminuria  
Turaj et al 
 
Microalbuminuria 
present 
Microalbuminuria 
absent 
Males 12(50%) 14(50%) 
Females 12(50%) 14(50%) 
 
Our study 
Our study Microalbuminuria 
present 
Microalbuminuria 
absent 
Males 18(36%) 14(28%) 
Females 12(24%) 6(12%) 
 
In our study there was difference in between male and female 
but not statistically significant but similar findings were not noted 
in turaj et al  
 H/o of previous vascular disease 
 
 
Microalbuminuria 
present 
Microalbuminuria 
absent 
Turaj et al 9(37.5%) 16(57.2%) 
Our study 7(14%) 1(2%) 
 
There is incidence of stroke is more in patients without 
microalbuminuria in turaj et al  but in our study there is a 
significant difference was there 7(14%) in  patients with 
microalbuminuria and 1(2%) in patients without mocroalbuminuria 
and it was statistically significant. 
 
 
 
 
 
SUMMARY 
1. The subjects were taken consists of 50 acute ischemic stroke 
patients of age 55.80 years  as cases  with 32 males and 10 females. 
2. The controls were  age and sex matched of 50  old stroke patients  
3. The cases and controls were matched with presenting factors  
4. Among the   case the 26(52%) were right sided hemiparaesis and 
20(40%) were left sided hemiparesis. 
5. Among the CT scan results predominant lesions were  middle 
cerebral artery . 
6. Patients with microalbuminuria has higher incidence with 
presenting factors such as aphasia, loss of consciousness. 
   H/o peripheral vascular events were higher in patients with micro 
albuminuria  which is statistically significant  
  H/o smoking also found to be higher in patients with micro 
albuminuria which is statistically significant. 
7. In our study with recent ischemic stroke 20 patients (40%) had 
Micro albuminuria  and among the controls only 7 patients had 
microalbuminuria. Hence patients with recent ischemic stroke were 
2.58 times were higher incidence of  microalbuminuria than 
without microalbuminuria and was found statistically significant 
with p= 0.447. 
8. There are 17/20 subjects with microalbuminuria (85%) had loss of 
consciousness whereas 8/30 subjects without microalbuminuria had 
loss of consciousness. Therefore microalbuminuria were found  to 
be associated  with severity of the stroke. 
9. The  Total cholesterol were 194.1±15.06 LDL were 110.1±9.01, 
HDL were 45.3±4.76 and triglyceride s 196.5±5.42  were found in  
subjects with microalbuminuria  whereas total cholesterol were 
196.6±12.23, LDL 105.5±7.40, HDL 45.3±4.76, triglycerides 
198.7±10.28.  This difference were not statistically significant. 
10.  The NIHSS scores were found to have high in subjects with 
microalbuminuria as compared to subjects without micro 
albuminuria. Hence microalbuminuria had significant correlation 
with the  severity of the stroke . 
11.  Functional assessment grading were done using modified rankins 
scale found to have higher  scores  in subjects with 
microalbuminuria than without microalbuminuria 
 CONCLUSION 
 
There are many studies that have documented 
microalbuminuria  as a risk factor for acute ischemic stroke. Our 
study demonstrated   microalbuminuria  in  (40%)  of non diabetic 
acute ischemic stroke and is consistent with previous study 
associating  microalbuminuria  in atherosclerotic vascular disease. 
 
In our study measuring the presence of microalbuminuria was  
found to be a  strong  predictor of stroke outcome after 6 weeks of 
stroke. The poor neurological deficit during the course of the 
disease correlates with microalbuminuria . This study gives the 
indirect prediction of microalbuminuria as a independent risk factor 
for stroke outcome. 
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PROFORMA 
Patient profile  
NAME:                                                                          OP/IP NO: 
AGE:                                                                              DOA:  
SEX:                                                                               DOD: 
OCCUPATION:                                                            ADDRESS: 
PRESENTING COMPLAINTS 
1. Paucity of movements of one side of the body 
Yes/No – 
Duration – 
2. Loss of consciousness 
Yes/No- 
Duration- 
3. Seizures  
Yes /No – 
Duration – 
Type       - 
4. Other symptoms 
PAST HISTORY 
Diabetes mellitus- 
HTN - 
Renal insufficiency- 
Liver disease- 
H/O vascular events- 
FAMILY HISTORY 
Diabetes mellitus-  
HTN- 
Cerebrovascular accidents- 
PERSONAL HISTORY 
Appetite- 
Diet- 
Sleep- 
Bladder movement- 
Bowel movement- 
Smoking – 
Alcohol intake- 
OBSTETRIC HISTORY 
         ( In females) 
GENERAL PHYSICAL EXAMINATION  
Built – poor/moderate/well 
Nourishment – poor/moderate/well 
Pallor- 
Icterus- 
Cyanosis- 
Clubbing- 
Lymphadenopathy- 
Oral cavity- 
Oedema- 
Weight- 
Height- 
Pulse- 
B.P- 
JVP- 
RR- 
Temperature- 
1. CNS EXAMINATION: 
Done by using NIHSS scoring less severe < 20                       
                              More severe > 20 
2.CARDIOVASCULAR SYSTEM  
Inspection – 
Palpation –  
Percussion – 
Auscultation – 
3. RESPIRATORY SYSTEM 
Inspection – 
Palpation – 
Percussion- 
Auscultation- 
4.ABDOMEN 
 
INVESTIGATIONS 
1. Urine analysis 
Sugar    - 
Albumin – 
Microscopy - 
2. Complete Haemogram 
Hb% - 
TC- 
DC- 
ESR- 
3. RBS 
Blood Urea – 
Serum Creatinine- 
4. Fasting Lipid profile 
TC –   HDL –  LDL –  
 TG – 
5. Chest X –ray PA view 
6. 12 lead ECG 
7. Echocardiogram 
8. C. T Brain 
9. Turbidimetry test for Microalbuminuria  
Functional assessment chart  
10. Modified Rankins criteria 
Less severe < 3 
More severe > 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
KEY TO MASTER CHART 
OP/IP No      -    Out patient /In  patient Number  
M                  -    Male 
F                   -     Female 
N                  -      No  
Y                  -      Yes  
Territory involved  
1. RACA  –  Right anterior cerebral artery infarct 
2. LACA  –  Left anterior cerebral artery infarct 
3. RMCA  –  Right middle cerebral artery infarct 
4. LMCA  –  Left middle cerebral artery infarct 
5. RPCA  –  Right posterior cerebral artery infarct 
6. LPCA  –  Left posterior cerebral artery infarct 
LOC   –  Loss of consciousness 
CBF           -         cerebral blood flow 
Seizures  
1. Generalised tonic clonic seizures  
2. Right focal seizures  
3. Left focal seizures. 
ANTIPLAGIARISM CERTIFICATE 
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